Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bortezomib resistance in CCRF-CEM cell line

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE74635 | GEO | 2015/11/04

SECONDARY ACCESSION(S): PRJNA301040

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Bortezomib resistance in CCRF-CEM cell line

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-11-04 | E-GEOD-74635 | biostudies-arrayexpress

Bortezomib resistance in CCRF-CEM cell line [GEP]

2015-11-04 | GSE74634 | GEO

Bortezomib resistance in CCRF-CEM cell line [CGH]

2015-11-04 | GSE74633 | GEO

Bortezomib resistance in CCRF-CEM cell line [miRNA]

2015-11-04 | GSE74632 | GEO

Bortezomib resistance in CCRF-CEM cell line [CGH]

Project description:Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the CCRF-CEM T-ALL cell line. On these subclones comparative Genome hybridization (arrayCGH) for DNA copy number analysis gene expression and micro-RNA expression arrays were performed. We performed comparative Genome hybridization (arrayCGH) for DNA copy number analysis on four different bortezomib resistant subclones of the CCRF-CEM cell line. The resistant subclones were compared to the parental CCRF-CEM wildtype cell line and reference DNA.

2015-11-04 | E-GEOD-74633 | biostudies-arrayexpress

Bortezomib resistance in CCRF-CEM cell line [GEP]

Project description:Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the CCRF-CEM T-ALL cell line. On these subclones comparative Genome hybridization (arrayCGH) for DNA copy number analysis gene expression and micro-RNA expression arrays were performed. We performed gene expression microarray analysis on four different bortezomib resistant subclones of the CCRF-CEM cell line. The resistant subclones were compaired to treated and untreated the parental CCRF-CEM wildtype cell line.

2015-11-04 | E-GEOD-74634 | biostudies-arrayexpress

Bortezomib resistance in CCRF-CEM cell line [miRNA]

Project description:Bortezomib is a proteasome inhibitor used in severel different hematological malignancies. Resistance to this drug is still poorly understood. In order get more insight in the resistance mechanism, we developed several bortezomib resistant subclones of the CCRF-CEM T-ALL cell line. On these subclones comparative Genome hybridization (arrayCGH) for DNA copy number analysis gene expression and micro-RNA expression arrays were performed. We performed micro-RNA on two different bortezomib resistant subclones of the CCRF-CEM cell line. The resistant subclones were compared to the parental CCRF-CEM wildtype cell line.

2015-11-04 | E-GEOD-74632 | biostudies-arrayexpress

Genome-wide analysis of gene expression in response to bortezomib treatment

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-07-02 | E-GEOD-41930 | biostudies-arrayexpress

Targeting RNA helicase ameliorates bortezomib resistance in glioblastoma via RNA dependent sequestration of protein phosphatase PPM1D

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-01 | GSE160875 | GEO

SSEA4 is a marker for chemotherapy resistance

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-11-19 | E-GEOD-57705 | biostudies-arrayexpress